Century Therapeutics, Inc. Public Float
Century Therapeutics, Inc. (IPSC) had Public Float of $212.51 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $212.51M.
- 2024-06-30: Entity Public Float $212.51M.
- 2023-06-30: Entity Public Float $131.78M.
- 2022-06-30: Entity Public Float $368.26M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $212.51M 10-K · filed 2026-03-12 |
| 2024-06-30 | $212.51M 10-K · filed 2025-03-19 |
| 2023-06-30 | $131.78M 10-K · filed 2024-03-14 |
| 2022-06-30 | $368.26M 10-K · filed 2023-03-16 |
| 2021-06-30 | $669.09M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |